Unico 3 is proud to announce its charity partnership with The Giles’ Trust, with the shared goal of making strides in the battle against brain tumours.
Brain tumours stand as the leading cause of mortality in adults and children under 40 in the UK. Unico 3 directors, having experienced the impact first-hand with a close family member undergoing over two decades of treatment at the Queen Elizabeth Hospital Birmingham, are committed to making a difference.
The partnership between Unico 3 and The Giles’ Trust was initiated after a chance meeting at a Sterling Networking Group, where Rebecca Dean, director at Unico3 and Karen Jones, fundraiser for the charity, recognised the potential to amplify their impact by working together.
Of the partnership, Rebecca commented:
“We at Unico 3, are enthusiastic about creating opportunities for The Giles’ Trust Brain Tumour Fund. Our collective aim is to increase awareness and help raise vital funds which will directly benefit brain tumour patients at the Queen Elizabeth Hospital Birmingham.”
This collaboration seeks to leverage the strengths and resources of both organisations to make a meaningful impact throughout the coming year. By combining efforts, Unico 3 will aim to help and support The Giles’ Trust to continue their great work, supporting brain tumour research, facilitating access to pioneering equipment, and providing crucial support for individuals and families affected by brain tumours.
For more information about The Giles’ Trust please visit https://gilestrust.org/
